- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A207
- A2-A208
- A1-A213
- A1-A214
- A1-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-13 (Saturday)
A1-A108
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:05 |
Welcome & Opening Remarks |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| 2 | 08:05-08:25 |
Super Selective cTACE in HCC: Asian Expertise, Standardization, and Its Role in Modern Treatment Algorithms |
Yozo Sato | Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan |
| 3 | 08:25-08:45 |
Why cTACE–Based Combination Strategies Matter in the Era of TKIs and Immunotherapy ? |
David C. Madoff | Yale School of Medicine, USA |
| 4 | 08:45-09:05 |
Evaluating cTACE in the Chinese HCC Treatment Paradigm: Rationale for Multimodal Combination and Conversion Strategies |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| 5 | 09:05-09:30 |
Panel discussion |
David C. Madoff | Yale School of Medicine, USA |
| 6 | 09:05-09:30 |
Panel discussion |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| 7 | 09:05-09:30 |
Panel discussion |
Yozo Sato | Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:00-10:15 |
dTACE with small size beads in metastatic liver cancer |
Chih-Horng Wu | National Taiwan University Hospital, Taiwan, China |
| 2 | 10:15-10:30 |
Biodegradable embolic agents in TACE |
Jiaywei Tsauo | Guangdong Provincial People's Hospital, China |
| 3 | 10:30-10:45 |
DynaCT and Advanced Image Guidance in Interventional Oncology and Embolization |
Bernhard Meyer | Hannover Medical School, Germany |
| 4 | 10:45-11:00 |
Cryoablation in benign and mallignant tumors |
Tang Alex | Subang Jaya Medical Centre，Malaysia |
| 5 | 11:00-11:15 |
Hemoptysis therapy: Tips&Tricks |
Ma Xu | Shanghai Pulmonary Hospital, China |
| 6 | 11:15-11:30 |
AI-driven capabilities to streamline workflows and empower confident decision-making in embolization |
Simone Henrichs | Siemens Healthineers AG, Germany |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 12:00-12:05 |
Opening Remarks |
Gao-Jun Teng | Zhongda Hospital, Southeast University, China |
| 2 | 12:05-12:15 |
Treatment Strategies for Gastrointestinal Bleeding |
Hiroshi Kondo | Teikyo University School of Medicine, Japan |
| 3 | 12:15-12:20 |
Discussion |
Shiro Miyayama | Fukui-ken Saiseikai Hospital, Japan |
| 4 | 12:20-12:30 |
Preoperative embolization of hypervascular spinal tumors |
Long Jin | Beijing Friendship Hospital, Capital Medical University, China |
| 5 | 12:30-12:35 |
Discussion |
Hiroshi Kondo | Teikyo University School of Medicine, Japan |
| 6 | 12:35-12:45 |
Transarterial ablation for small HCC using an ASAHI's microcatheter system |
Shiro Miyayama | Fukui-ken Saiseikai Hospital, Japan |
| 7 | 12:45-12:55 |
Discussion |
Long Jin | Beijing Friendship Hospital, Capital Medical University, China |
| 8 | 12:55-13:00 |
Discussion |
Shiro Miyayama | Fukui-ken Saiseikai Hospital, Japan |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:00-13:10 |
Efforts to Prolong the Longtime Survival of Pancreatic Cancer |
Bai-Yong Shen | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China |
| 2 | 13:10-13:20 |
IRE in Pancreatic Cancer: Integration into Multimodality Therapyand Margin Accentuation |
Praveen Peddu | King's College Hospital, London, UK |
| 3 | 13:20-13:30 |
Diagnosis and treatment of biliopancreatic duct diseases with zero incision under SMIS |
En-Qiang Linghu | The First Medical Center of PLA General Hospital, China |
| 4 | 13:30-13:40 |
IRE synchronous chemotherapy and immunotherapy for pancreatic cancer |
Li-Zhi Niu | Fuda Cancer Hospital, China |
| 5 | 14:00-14:30 |
Discussion |
A LL |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 15:00-15:10 |
Strategies to Enhance Outcomes of SIRT in Large HCC |
Sanjay Saran Baijal | Medanta – The Medicity, India |
| 2 | 15:10-15:20 |
Evaluation of extrahepatic collateral arteries in HCC in a single center |
Gantulga Vanchinsuren | Second State Center Hospital, Mongolia |
| 3 | 15:20-15:30 |
High dose SIRT/TARE for treating large HCCs |
Muhammad Ali Rasheed | Services Hospital Lahore |
| 4 | 15:30-15:40 |
The Tumor-Donor-Recipient Fusion Research Modality in Liver Transplant Oncology |
Xiao Xu | Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China |
| 5 | 15:40-15:50 |
Yttrium-90 SIRT Clinical Decision-Making and Outcomes in Unresectable Hepatocellular Carcinoma Patients with Elevated Lung Shunt Fraction |
Jing-Qin Ma | Zhongshan Hospital Affiliated to Fudan University, China |
| 6 | 16:00-16:30 |
Discussion |
A LL |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:30-16:40 |
Early TIPS in ascites |
Edward W. Lee | UCLA Medical Center, USA |
| 2 | 16:40-16:50 |
A single-center retrospective analysis of risk factors for poor survival outcomes in patients with decompensated liver cirrhosis after TIPS 1year later |
Qing Wang | Hunan Provincial People's Hospital, China |
| 3 | 16:50-17:00 |
Current Status of TIPS in India |
Amar Mukund | Institute of Liver and Biliary Sciences, India |
| 4 | 17:00-17:10 |
Advances in Interventional Therapies for Portal Hypertension–Related Complications: Perspectives from the Baveno Consensus |
Xue-Feng Luo | West China Hospital, Sichuan University, China |
| 5 | 17:10-17:30 |
Discussion |
A LL |
